New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Study reveals clues to how Eastern equine encephalitis virus invades brain cells

Study reveals clues to how Eastern equine encephalitis virus invades brain cells

byWashington University School of MedicineCredit: Pixabay/CC0 Public DomainAn atomic-level investigation of how Eastern equine encephalitis virus binds to a key receptor and gets inside of cells
Public Health & Prevention January 26,2024
Study reveals clues to how Eastern equine encephalitis virus invades brain cells

Study reveals clues to how Eastern equine encephalitis virus invades brain cells

byWashington University School of MedicineCredit: Pixabay/CC0 Public DomainAn atomic-level investigation of how Eastern equine encephalitis virus binds to a key receptor and gets inside of cells
Public Health & Prevention January 26,2024
Imetelstat leads to durable red blood cell transfusion independence

Imetelstat leads to durable red blood cell transfusion independence

by Elana GotkineFor heavily transfused patients with lower-risk myelodysplastic syndromes (LR-MDS) who are not responding to or are ineligible for erythropoiesis-stimulating agents (ESAs), the competi
Breakthroughs January 26,2024
Imetelstat leads to durable red blood cell transfusion independence

Imetelstat leads to durable red blood cell transfusion independence

by Elana GotkineFor heavily transfused patients with lower-risk myelodysplastic syndromes (LR-MDS) who are not responding to or are ineligible for erythropoiesis-stimulating agents (ESAs), the competi
Breakthroughs January 26,2024
Supercharging CAR-T cells for cancer treatment

Supercharging CAR-T cells for cancer treatment

byEcole Polytechnique Federale de LausanneIL-10-expressing CAR T cells counter dysfunction in tumors.a, Schematic depicting the HER2 CAR and IL-10 HER2 CAR constructs; scFv, single-chain v
Oncology January 26,2024
Supercharging CAR-T cells for cancer treatment

Supercharging CAR-T cells for cancer treatment

byEcole Polytechnique Federale de LausanneIL-10-expressing CAR T cells counter dysfunction in tumors.a, Schematic depicting the HER2 CAR and IL-10 HER2 CAR constructs; scFv, single-chain v
Oncology January 26,2024
FDA asked to consider party drug MDMA as treatment for PTSD

FDA asked to consider party drug MDMA as treatment for PTSD

by Robin FosterA California company has asked the U.S. Food and Drug Administration to approve MDMA, the active ingredient in party drugs like molly and ecstasy, as a treatment for post-traumatic stre
Breakthroughs January 26,2024
FDA asked to consider party drug MDMA as treatment for PTSD

FDA asked to consider party drug MDMA as treatment for PTSD

by Robin FosterA California company has asked the U.S. Food and Drug Administration to approve MDMA, the active ingredient in party drugs like molly and ecstasy, as a treatment for post-traumatic stre
Breakthroughs January 26,2024
How three infectious disease agents evade the immune system

How three infectious disease agents evade the immune system

byNanyang Technological UniversityTransmission electron microscope image of a respiratory syncytial virus particle. Credit: Assoc Prof Richard SugrueCOVID-19 cast a glaring spotlight on the deva
Public Health & Prevention January 26,2024
How three infectious disease agents evade the immune system

How three infectious disease agents evade the immune system

byNanyang Technological UniversityTransmission electron microscope image of a respiratory syncytial virus particle. Credit: Assoc Prof Richard SugrueCOVID-19 cast a glaring spotlight on the deva
Public Health & Prevention January 26,2024
The quest to conquer latent HIV and end the AIDS pandemic

The quest to conquer latent HIV and end the AIDS pandemic

byAmerican Society for MicrobiologyHIV-1 Latency can occur in a number of different anatomical sites, as well as multiple immunological cell types. Latent virus is not detectable by the host imm
Dermatology January 26,2024
The quest to conquer latent HIV and end the AIDS pandemic

The quest to conquer latent HIV and end the AIDS pandemic

byAmerican Society for MicrobiologyHIV-1 Latency can occur in a number of different anatomical sites, as well as multiple immunological cell types. Latent virus is not detectable by the host imm
Dermatology January 26,2024
Clinical trial: New dual therapy could revolutionize treatment of urothelial and bladder cancers

Clinical trial: New dual therapy could revolutionize treatment of urothelial and bladder cancers

by Georgia Gowing,Macquarie UniversityDr. Alison Zhang. Credit: Macquarie UniversityAn international clinical trial of a treatment for advanced urothelial cancer has found a new dual therapy can
Breakthroughs January 26,2024
Clinical trial: New dual therapy could revolutionize treatment of urothelial and bladder cancers

Clinical trial: New dual therapy could revolutionize treatment of urothelial and bladder cancers

by Georgia Gowing,Macquarie UniversityDr. Alison Zhang. Credit: Macquarie UniversityAn international clinical trial of a treatment for advanced urothelial cancer has found a new dual therapy can
Breakthroughs January 26,2024
Knocking out part of the innate immune system to improve cancer therapy

Knocking out part of the innate immune system to improve cancer therapy

by Justin Jackson , Medical XpressCredit: CC0 Public DomainResearchers at Shanghai Jiao Tong University School of Medicine, China, have discovered that shutting down part of the innate immune system i
Oncology January 26,2024
Knocking out part of the innate immune system to improve cancer therapy

Knocking out part of the innate immune system to improve cancer therapy

by Justin Jackson , Medical XpressCredit: CC0 Public DomainResearchers at Shanghai Jiao Tong University School of Medicine, China, have discovered that shutting down part of the innate immune system i
Oncology January 26,2024
Experimental drug that alters gut microbiome shows promise for long COVID relief

Experimental drug that alters gut microbiome shows promise for long COVID relief

by Mary Van Beusekom, CIDRAPProportion of PACS symptoms alleviation by six months. Credit:The Lancet Infectious Diseases(2023). DOI: 10.1016/S1473-3099(23)00685-0A randomized controlled tr
Breakthroughs January 26,2024
Experimental drug that alters gut microbiome shows promise for long COVID relief

Experimental drug that alters gut microbiome shows promise for long COVID relief

by Mary Van Beusekom, CIDRAPProportion of PACS symptoms alleviation by six months. Credit:The Lancet Infectious Diseases(2023). DOI: 10.1016/S1473-3099(23)00685-0A randomized controlled tr
Breakthroughs January 26,2024
Research shows immune cells shape lung tissue before birth, provides new avenues for treating respiratory diseases

Research shows immune cells shape lung tissue before birth, provides new avenues for treating respiratory diseases

byWellcome Trust Sanger InstituteImmunohistochemistry showing immune cells spatially and temporally in fetal lungs. Credit: Josephine L BarnesImmune cells play an active and intimate role in dir
Pulmonology January 26,2024
Research shows immune cells shape lung tissue before birth, provides new avenues for treating respiratory diseases

Research shows immune cells shape lung tissue before birth, provides new avenues for treating respiratory diseases

byWellcome Trust Sanger InstituteImmunohistochemistry showing immune cells spatially and temporally in fetal lungs. Credit: Josephine L BarnesImmune cells play an active and intimate role in dir
Pulmonology January 26,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com